Heparin-binding protein levels correlate with aggravation and multiorgan damage in severe COVID-19.
ERJ Open Res
; 7(1)2021 Jan.
Article
Dans Anglais
| MEDLINE | ID: covidwho-1076123
ABSTRACT
BACKGROUND:
Critically ill coronavirus disease 2019 (COVID-19) patients may suffer persistent systemic inflammation and multiple organ failure, leading to a poor prognosis. RESEARCH QUESTION To examine the relevance of the novel inflammatory factor heparin-binding protein (HBP) in critically ill COVID-19 patients, and evaluate the correlation of the biomarker with disease progression. STUDY DESIGN ANDMETHODS:
18 critically ill COVID-19 patients who suffered from respiratory failure and sepsis, including 12 cases who experienced a rapidly deteriorating clinical condition and six cases without deterioration, were investigated. They were compared with 15 age- and sex- matched COVID-19-negative patients with respiratory failure. Clinical data were collected and HBP levels were investigated.RESULTS:
HBP was significantly increased in critically ill COVID-19 patients following disease aggravation and tracked with disease progression. HBP elevation preceded the clinical manifestations for up to 5â days and was closely correlated with patients' pulmonary ventilation and perfusion status.INTERPRETATION:
HBP levels are associated with COVID-19 disease progression in critically ill patients. As a potential mediator of disease aggravation and multiple organ injuries that are triggered by continuing inflammation and oxygen deficits, HBP warrants further study as a disease biomarker and potential therapeutic target.
Texte intégral:
Disponible
Collection:
Bases de données internationales
Base de données:
MEDLINE
Type d'étude:
Études expérimentales
/
Étude pronostique
langue:
Anglais
Année:
2021
Type de document:
Article
Pays d'affiliation:
23120541.00741-2020
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS